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Abstract
DNA double-strand break (DSB) is a type of the most critical DNA lesions, and if not 
repaired promptly, it can result in cell death or a wide variety of genetic alterations 
including genome instability, large- or small-scale deletions, chromosome loss, loss of 
heterozygosity, and translocations. DSBs are repaired by double-strand break repair 
(DSBR), including nonhomologous end-joining (NHEJ) and homologous recombination 
(HR) pathway, and defects in these pathways cause genome instability and promote 
tumorigenesis. Accumulating evidence has demonstrated that the superfamily of deubiq-
uitinases (DUBs) can regulate the action and stability of DNA repair enzymes involving 
in DSBR via modifying ubiquitination levels, a reversible posttranslational modification 
pathway. In this review, we will discuss ubiquitination/deubiquitination modification 
involving in DSBR genes, the role of DUBs in DSBR and corresponding mechanisms, and 
the potential effects of this modification on human diseases.
Keywords: double-strand break repair, deubiquitinase, ubiquitination, deubiquitination, 
double-strand break
1. Introduction
DNA double-strand break (DSB) is a fatal alteration in the chemical structure of DNA; if it 
has not been repaired in time, it may destroy the stability of genome and lead to a series of 
human diseases. Usually, they result from a variety of causes including abnormal metabolic 
process, ionizing radiation, ultraviolet radiation, and active oxygen damage factors [1, 2]. In 
organism, DNA double-strand break repair (DSBR), a complex reaction system consisting 
of nonhomologous end-joining (NHEJ) and homologous recombination (HR) pathway, can 
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repair DSBs [3, 4]. Accumulating evidence has demonstrated that ubiquitination and deubiq-
uitination modification play a vital role in controlling the capacity of DSBR via regulating the 
action and stability of DNA repair enzymes involving in DSBR pathway. In the past decades, 
there has been great advance in the role of deubiquitinases (DUBs) in DNA damage repair. 
Here, we reviewed ubiquitination/deubiquitination modification of DSBR genes, the role of 
DUBs in DSBR and corresponding mechanisms, and the potential effects of this modification 
on human diseases.
2. Ubiquitination and deubiquitination
Ubiquitin is an important single-chain polypeptide consisting of 76 amino acid residues and 
ubiquitously exists in almost all eukaryotic cells and tissues [5, 6]. This polypeptide is charac-
terized by highly conserved protein from yeast to human [6] and is invariant in higher plants 
and differs by only three residues from animals [7]. Structurally, ubiquitin polypeptide chain 
appears to be a highly compact β-grasp fold with an α-helix in the cavity formed by a five-
strand mixed β-sheet and a marked hydrophobic core formed between the β-sheet and the 
α-helix [8]. A flexible six-residue tail in the C-terminal of ubiquitin protrudes from β-grasp 
fold and is requested for forming the bond between ubiquitin and its substrate [9].
Ubiquitination is defined as the process that ubiquitin attaches to its target proteins via cataly-
sis of enzymes. This process is a reversible posttranslational modification that can regulate 
various processes including cell proliferation, apoptosis, transcription, protein stability and 
translocation, and DNA damage repair [10–12]. Ubiquitination process is an ATP-dependent 
enzymatic cascade reaction [13, 14]. During cascades reaction, C-terminal of ubiquitin is first 
adenylated by ubiquitin-activating enzyme (E1) via forming a bond between the adenosine 
monophosphate (AMP) and the C-terminal glycine carboxyl group of ubiquitin, and subse-
quently, the E1 cysteine side chain directly binds to C-terminal and results in the formation of 
a thiol-ester linkage. Then, the activated ubiquitin is presented to the active cysteine in a ubiq-
uitin-conjugating enzyme (E2). The E2 delivers the ubiquitin to its substrate cooperating with 
ubiquitin ligases (E3), which plays a role in substrate recognition. Finally, the C-terminal gly-
cine of the ubiquitin binds to a lysine residue of the substrate with an isopeptide bond. After 
multiple cycles of cascade reaction, substrate will bind one or more polyubiquitin chains that 
are formed between the lysine side of one ubiquitin and the C-terminal carboxyl group of 
another ubiquitin [13, 14]. The 26S proteasome can specifically recognize these target proteins 
with ubiquitination modification and lead them into ubiquitin-proteasome pathway (UPP) 
for inducting protein degradation, a key role of ubiquitination. However, UPP is not the only 
role of ubiquitination. Ubiquitination can also regulate protein activity and the interaction 
among proteins [13, 14].
Deubiquitination is the reverse process of ubiquitination and regulated by deubiquitinases 
(DUBs). DUBs, also known as deubiquitinating enzymes, can cleave the bonds between sub-
strate and polyubiquitin chains and improve the stability of substrate. They can also remove 
single ubiquitin molecule from polyubiquitin chains. Until now, approximately 561 DUBs 
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have been identified in the human genome [15], and most of them are cysteine proteases. 
According to the difference in their structure and function, DUBs are divided into six classes: 
ubiquitin-specific proteases (USPs), ubiquitin carboxy-terminal hydrolases (UCHs), ovar-
ian tumor proteases (OTUs), Machado-Joseph disease protein domain proteases (MJDs), 
JAMM/MPN domain-associated metallopeptidases (JAMMs), and the monocyte chemotactic 
protein-induced protein (MCPIP) family. These enzymes can stabilize protein and play a cru-
cial role in the life process [13, 14].
3. DSBs and DSBR pathways
3.1. DSBs and DSB response
DSBs are vital DNA damages caused by a variety of physiological or pathological factors. 
V(D)J recombination has been identified as the only physiological reason inducing DSBs that 
result from the recombination of variable (V), diversity (D), and joining (J) gene segments. It 
often appears in the early development process of the vertebrate immune system. Evidence 
has shown that diverse immunoglobulins and T-cell receptors are generated due to this spe-
cial recombination pathway. During V(D)J recombination, DNA strands are cut by RAG-1 
and RAG-2 protein between the recombination signal sequences (RSS) heptamer and the 
flanking sequence and result in the formation of DSBs [16, 17], whereas the ends of the broken 
strands are subsequently processed and connected through NHEJ pathway [18].
For pathological factors, reactive oxygen species (ROSs) resulting from cellular oxidation are 
one main source of pathological DSBs. Studies have shown that about one percent of the 
oxygen that we breathe is converted into oxidative free radicals and ultimately can cause 
DSBs in different degrees [19]. Pathological DSBs can also arise from DNA replication across 
a nick that is caused by exogenous or endogenous sources. Such ionizing radiation as X-rays 
and gamma rays may produce free radicals and induce the formation of DSBs [20]. This type 
of DSBs only occurs in the S phase and is repaired through HR pathway. Additionally, one 
unusual cause producing DSBs is the topoisomerase II poisons that can lead to DSBs forma-
tion, apoptotic cell death, and genomic instability via stabilizing the DNA topoisomerase II 
cleavable complexes [21]. Another unusual cause is physical stress on the DNA duplex, which 
may be from the mitotic spindle on chromosomal fusions or telomere failures [22].
Studies have shown that DSBs can induce DNA damage response, and such E3 ligases as 
ring finger protein (RNF8) subsequently accumulate around the lesions. After that, RNF8-
recruiting RNF168 promotes histone H2A Lys13,15 mono-ubiquitination (H2AK13, 15ub). 
Therefore, the accumulation of DNA-repair regular factors, such as receptor-association pro-
tein (RAP80) and TP53 binding protein (53BP1), is allowed [23–26]. Finally, the ataxia telan-
giectasia mutated (ATM) and ATM/rad3-related (ATR) kinases, a central regulator of DSB 
response, are activated and induce the activation of Chk1 and Chk2 kinases and TP53 protein. 
The activated Chk1 and Chk2 kinases arrest cell cycle to obtain sufficient time for DNA repair, 
while activate TP53 induces cell death [27, 28].
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3.2. DSBR pathways
Merely one DSB that triggers apoptosis or destroys a critical gene is enough to lead a cell 
to death [29], whereas losing ability to repair DSBs can also lead to genome rearrangement 
and cellular transformation [30]. In organism, the two primary pathways to correct DSBs are 
known as HR pathway and NHEJ pathway. For NHEJ pathway, it can repair DSBs with non-
homological damaged ends and is the primary DSBR pathway in mammalian cells. This path-
way consists of classical-NHEJ (C-NHEJ) and alternative-NHEJ (A-NHEJ). In C-NHEJ, Ku 
heterodimer (Ku70 and Ku80 subunits) recognizes and binds to the ends of a DSB to prevent 
the free ends from degradation. Subsequently, DNA-dependent protein kinase catalytic sub-
unit (DNA-PKcs) is recruited and then binds to Ku heterodimer to recruit XRCC4 and DNA 
ligase 4 (LIG4). XRCC4 and LIG4 form a complex with XLF to ligate the broken ends [31, 32]. 
Until now, although the detailed mechanism of NHEJ is poorly understood, a recent study 
has partly revealed the mechanism about how the complex of XRCC4, LIG4, and XLF con-
nects the fragments of broken DNA [33]. It has shown that XRCC4-XLF complex first bridges 
the two DNA molecules generated by DSBs, and the bridge can slide along the DNA. Then, 
the ends of broken DNA are rapidly reconnected. Evidence from molecular epidemiologi-
cal and genetical studies displays that low or losing capacity of NEEJ pathway is positively 
associated with the deficiency of immune reaction [34, 35]. For example, about 15% of human 
severe combined immune deficiency (SCID) has been observed to feature low NHEJ capacity 
caused by null mutations of Artemis gene [34, 35]. Patients carrying the mutations in the DNA 
ligase IV gene that is crucial in NHEJ pathway presented some NBS-like features; however, 
cancers were not observed on these patients [36].
For HR pathway, it was first illuminated in Escherichia coli and Saccharomyces cerevisiae [37], 
and the similar mechanisms of the key reaction in HR pathway are observed in bacteria, yeast 
and human cells. An intact double-strand DNA that has highly homologous sequence of the 
damaged molecule is needed to act as the template to direct repair [38]. HR pathway includes 
three main steps: termini procession, strand invasion and branch migration, and Holliday 
junction formation. The ends of DSB are first processed by a nuclease, such as Mre11-Rad50-
NBS1 (MRN) complex, and produce a single-stranded region with a 3′ overhang. Replication 
protein A (RPA) subsequently binds to the single-strand region for stabilizing and protecting 
this single-strand status [39, 40]. The core procedure of HR pathway is RAD51-depended 
strand invasion and branch migration. RAD51 displaces the RPA from single-strand DNA 
to form a nucleoprotein filament and then directs the later to recognize homologous duplex 
DNA [41]. DNA strand exchange generates a Holliday junction between the homologous 
damaged and undamaged DNAs under the condition of cooperating RAD51 with RAD52, 
RAD54, and RAD55/57 protein. Finally, the MUS81/MMS4 can resolve Holliday junction to 
stop the process of HR pathway [3].
Except for above-mentioned directly regulated proteins, DSB response factors (including 
ATM/ATR and BRCA1/BRCA2) can indirectly regulate the capacity of HR pathway [42–46]. 
The defects of ATM may alter kinetics of radiation-induced RAD51 formation and the hall-
mark of RAD51 activation [42]. ATM/ATR can also mediate the phosphorylation of PALB2 to 
promote the formation of RAD51 nucleofilaments [43]. However, roles of ATM and ATR in 
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HR pathway are still poorly understood. BRCA1 is a protein with 1863 amine acids encoded 
by breast cancer susceptibility gene and can target DSB lesion through its N-terminal RING 
domain binding to BRCA1-associated RING domain 1 (BARD1) [44]. BRCA1 can also pro-
mote HR pathway via cooperating with RAD51 and forming the complex of BRCA1-PALB2-
BRCA2-RAD51 (BRCC) [44]. Surprisingly, BRCA1 can also prevent HR pathway by its 
incorporating into the complex of BRCA1-Abraxas-RAP80-MERIT40 (BRCA1-A). This may 
be because BRCA1-A can limit DNA end-resection or sequester BRCA1 away from HR sites 
by binding to RNF8/RNF168-ubiquitylated chromatin [45, 46]. Studies have shown that low 
or lost capacity of HR pathway resulting from these causes may cause a series of cancer-prone 
diseases, including ataxia telangiectasia (AT), Nijmegen breakage syndrome (NBS), Bloom 
syndrome, Werner syndrome, and Fanconi anemia, reviewed by Thompson and Schild [47].
4. Deubiquitinases regulating DSBR
4.1. USPs
USPs, the largest subfamily of DUBs with approximately 100 members and the most divers 
structures, belong to cysteine protease family (clan CA, family C19) and were first identified 
in Saccharomyces cerevisiae [48]. The size of USPs is ranging between 330 and 3500 amino acids, 
with 800 and 1000 residues. These DUBs have three functional domains: a catalytic domain, a 
protein-protein interaction domain, and localization domain [48]. In the catalytic domain, USPs 
are marked with two short and well-conserved sequences, also called as the N-terminal Cys-box 
and the C-terminal His-box. These sequences are essential for catalytic activity of USPs [48, 49], 
while other domains provide the information of binding to their target protein. Interestingly, 
almost all the UBP deubiquitinases display a conserved three-domain architecture, comprising 
Fingers, Palm, and Thumb, and their C terminus are settled in the active site between the Palm 
and the Thumb, except for CYLD that has an obviously truncated Fingers subdomain [50, 51]. 
A later study has shown that the core catalytic domain of USPs contains six conserved boxes, 
and that boxes 1 and 2, boxes 3 and 4, and boxes 5 and 6 formed Thumb subdomain, Fingers 
subdomain, and Palm subdomain, respectively [52]. USPs have been found to involve in many 
diseases, such as cancer, inflammation and viral diseases [53]. At least 15 of USPs, including 
USP1, USP3, USP4, USP6, USP7, USP10, USP11, USP15, USP20, USP26, USP29, USP37, USP42, 
USP44, and USP51, can regulate DSBR.
USP1 contains 785 amino acids, and its catalytic domain is one of the largest among all USPs. 
Although two insertions between boxes 2 and 3 and between boxes 5 and 6 have been iden-
tified to locate away from the ubiquitin binding site of USP1, it is still not clear whether 
these insertions can reach the active site [52]. As USP1 has been reported to overexpress in 
osteosarcoma and non–small cell lung cancer, inhibitors of USP1 are supposed to have anti-
cancer potential [54, 55]. Interestingly, USP1 can be stabilized by USP1-associated factor 1 
(UAF1) that can increase the catalytic activity of USP1 [56]. This indicates that USP1 need 
to form a complex with UAF1 to carry out its functions. A recent study has further proved 
that three cell clones, USP1−/−, UAF1−/−/−, and USP1−/− UAF1−/−/− double-knockout cells, showed 
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 hypersensitivity to both camptothecin and poly (ADP-ribose) polymerase (PARP), suggesting 
that the USP1/UAF1 complex can promote HR capacity. Moreover, the USP1/UAF1 complex 
promoting HR capacity is at least in part associated with the suppression of NHEJ, although 
corresponding mechanisms still need to be further researched [57].
USP3 is a nuclear protein that presents in the chromatin fraction and is also a chromatin-asso-
ciated DUB [58]. In 1999, Sloper-Mold et al. firstly identified and analyzed USP3 and found 
that a human USP3 gene probe detected two different mRNA transcripts that were expressed 
at low levels in all examined tissues [59]. USP3 is required for the deubiquitination of H2A 
and H2B to revert corresponding mono-ubiquitination. It has been displayed that USP3 can 
also regulate the cellular levels of ubiquitinated H2A and H2B (uH2A and uH2B), as H2A 
and H2B are the two major mono-ubiquitinated chromosomal protein [13, 58]. In addition, 
uH2A and uH2B have been revealed to associate with transcriptional regulation, where USP3 
potentially plays a vital role [14]. Furthermore, the results from a study on mice with the 
deficiency of USP3 have shown that these mice can develop tumor spontaneously, and cells 
with the deficiency of USP3 fail to preserve chromosomal integrity [60]. For DSBR pathway, 
USP3 plays a key role in regulate DSB response. Transient USP3 silencing will cause sponta-
neous DNA damage, and DNA damage response will be enhanced at the same time [60]. The 
ubiquitination of histone H2A and γH2AX initiated by RNF168 and RNF8 in DSB response 
generates a cascade reaction and results in the accumulation of DSBR enzymes, whereas USP3 
can oppose RNF168 and RNF8 via deubiquitination modification for the ubiquitinated H2A 
and γH2AX. Moreover, ectopic expression of USP3 can also block the accumulation of down-
stream repair enzymes such as BRCA1 and 53BP1 [61].
Except for USP3, several other USPs (including USP6, USP51, USP29, and USP44) can also 
deubiquitinate H2A [26, 62, 63]. Among these USPs, USP51 acts as a DUB for histone H2B 
mono-ubiquitination (H2Bub1), and the depletion of USP51 will suppress DSB reaction and 
tumor growth [64].
USP4, also named as ubiquitous nuclear protein (UNP), was initially found to promote carci-
nogenesis of lung and act as an oncogene [65, 66]. The following studies showed that USP4 is 
overexpressed in several types of human cancers such as hepatocellular carcinoma and plays 
a crucial role in the progression of tumorigenesis [67, 68]. Growing evidence has exhibited that 
USP4 affecting tumorigenesis may be correlated with abnormal DSBR capacity [67]. During 
DSBR pathway, USP4 may display its regulation functions on DSBR in several different pro-
cesses, including DSB response and HR capacity. It has been identified to act as an important 
TP53 regulator that can decrease TP53 by deubiquitinating and stabilizing ARF-BP1, a ubiqui-
tin ligase for p53 degradation [67]. During HR pathway, USP4 is required for CtIP recruitment 
to DNA damage site. It also regulates the resection of DNA DSBs via interacting with CtIP 
and the MRE11-RAD50-NBS1 (MRN) complex. The depletion of USP4 may abolish DNA end 
resection [69]. In addition, USP4 is ubiquitinated on multiple sites, and auto-deubiquitination 
of USP4 can promote CtIP recruitment and affect HR capacity [70].
USP11 and USP15 are two paralogs of USP4, and all of them share a common functional 
domain consisting of two ubiquitin-like (UBL) and a motif with ubiquitin-specific protease 
(DUSP) activity [71, 72]. USP11 is identified as a component of HR pathway, but the molecular 
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mechanism is not clear [73], while USP15 is a DUB for murine double minute-2 (Mdm2), one 
of the E3 ligases that play a major role in regulating TP53 [74]. Thus, cell apoptosis induced 
by TP53 in DSB response may be inhibited by USP15 via deubiquitinating and stabilizing 
Mdm2. Except for USP15, USP26 can also deubiquitinate Mdm2 and play the same role as 
USP15 regulating TP53 [75]. Furthermore, USP26 and USP37 have been shown to inhibit the 
formation of BRCA1-A and promote the formation of BRCC. This function may involve in 
HR pathway [76]. However, further studies are needed to elucidate how USP26 and USP37 
regulate HR pathway.
USP7, also called herpesvirus-associated ubiquitin-specific protease (HAUSP), is identified 
to act as a factor that promotes viral lytic growth, because it is associated with a herpesvi-
rus protein ICP0 that is crucial for the viral lytic cycle [77, 78]. Substrates of USP7 are wide-
spread, and a large part of them are tumor suppressors or oncogenes, such as TP53, PTEN, 
Chk1, Mdm2, and FOXO [79]. USP7 can regulate these tumor suppressors and play a key 
role in DSB response [80–82]. For example, USP7 directly deubiquitinates Chk1 in vivo and in 
vitro [83]; however, its family brother USP20 can only indirectly enhance the activity of ATR-
Chk1 signaling by deubiquitinating Claspin [80]. Interestingly, deubiquitination of TP53 by 
USP7 prevents TP53 from degradation, whereas deubiquitination of Mdm2 by USP7 increases 
ubiquitination of TP53 and promotes the degradation of TP53 [81, 82]. This implies that the 
regulation of TP53 by USP7 is very complicated. Although USP7 displays its deubiquitination 
potential for both TP53 and Mdm2 that are substrates each other, this regulation potential is 
affected by different modificative status [81, 82]. Studies have shown that TP53 and Mdm2 
bind to the same domain of USP7, but the binding capacity of Mdm2 is stronger except for 
phosphorylated status of Mdm2 induced by DNA damages [81, 82]. Additionally, USP10, 
USP29, and USP42 can deubiquitinate TP53, as well as USP7 [84–86]. However, they do not 
have the ability of deubiquitinating Mdm2. Thus, different USPs may exhibit different regu-
lative potential for DSBR pathway via affecting different DNA repair factors such as Chk1, 
TP53, Mdm2, and so on [80–82] (Table 1).
4.2. OTUs
OTUs are divided into three subclasses: Otubians, A20-like OTUs, and other OTUs [91]. 
Otubians consist of OTUB 1 and OTUB 2 that are the first two proteins identified to display 
the DUB activity in vitro [92]. Structurally, OTUs are partly similar to USPs, exception for the 
incomplete catalytic triad [93, 94]. OTUs functionally involve in the regulation of diverse pro-
gresses, such as virus-triggered interferon induction, T cell anergy, and deubiquitination of 
p53 [87, 95, 96]. Interestingly, OTUB1 is a Lys48-specific DUB that can cleave ubiquitin from 
branched-polyubiquitin chains but not from ubiquitinated substrates. This DUB can bind to 
UBC13 (a cognate E2 enzyme for RNF168) and enhance DSB response potential via suppress-
ing RNF168-dependent polyubiquitination but not via its catalytic ability [88]. OTUB1 also has 
the potential for directly deubiquitinating and stabilizing TP53 protein, which results in the 
decrease of cell death because of the increasing TP53 function [87]. Moreover, p53 is also the 
substrate of another OTU, OUTD5 [89]. OUTD5 has been shown to cleave the polyubiquitin 
chain from an essential type I interferon adaptor protein TRAF3 to interrupt the type I inter-
feron signaling cascade [97]. As a DUB for p53, it can form a direct complex with p53 and is 
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required for the p53-dependent apoptosis in response to DSB. Recently, increasing evidence has 
exhibited that the dysregulation of this DUB may involve in the development of several types 
of cancer, such as lung, colorectal, and colon cancer [98–100]. Taken together, the regulation of 
OTUs may result in the defects of DSBR and ultimately promote damaged-cell carcinogenesis.
4.3. JAMM/MPN domain-associated metallopeptidases (JAMMs)
JAMMs, the important members of metalloproteinase (MMP), contain JAMM/MPN domain-
associated metallopeptidases sequences. These sequences include three conserved residues 
(two His and one Asp) that make up of catalytic center with two zinc ions [101]. The 26S 
proteasome-associated PAD1 homolog 1 (POH1) is a representative member of JAMMs and 
plays a key role in DSBR pathway. POH1 has been shown to be required for HR, which 
was supposed to associate with its ability to restrict 53BP1 through cleaving ubiquitin from 
the polyubiquitin chains of K63 protein. However, the result from another study showed 
DUB Substrates Process Reference
USP1 Unclear Promote HR and partly suppress NHEJ [57]
USP3 H2A, γH2AX Suppress DNA DSB response [61]
USP4 ARF-BP1, USP4 Suppress p53-dependent apoptosis in DSB response [67, 70]
USP6 H2A Suppress DNA DSB response [26]
USP7 Chk1, p53, Mdm2 Promote p53-dependent apoptosis in DSB response [81–83]
USP10 p53 Promote p53-dependent apoptosis in DSB response [84]
USP11 unclear Promote HR [73]
USP15 Mdm2 Suppress p53-dependent apoptosis in DSB response [74]
USP20 Claspin Promote DNA DSB response [80]
USP26 Mdm2 Suppress p53-dependent apoptosis in DSB response and promote 
HR
[75, 76]
USP29 H2A, p53 Suppress DNA DSB response and promote p53-dependent 
apoptosis in DSB response
[63, 85]
USP37 Unclear Promote HR [76]
USP42 p53 Promote p53-dependent apoptosis in DSB response or promote DSB 
response
[86]
USP44 H2A Suppress DNA DSB response [63]
USP51 H2A, H2B Suppress DNA DSB response [62, 64]
OTUB1 p53 Promote p53-dependent apoptosis in DSB response not via its 
catalytic ability
[87, 88]
OTUD5 p53 Promote p53-dependent apoptosis in DSB response [89]
POH1 K63 Promote HR but not via deubiquitinating K63 [90]
Table 1. DUBs regulate DNA DSBR.
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that POH1-regulating HR process was independent of 53BP1 [90]. Thus, further studies are 
needed to elucidate detailed regulative mechanisms.
5. Summary and future directions
DSBR is a crucial DNA repair pathway and requests a series of DNA repair enzymes, whose 
activation is usually controlled via the post-translational modification regulation. In the regu-
lation of DSBR capacity, DUBs play a vital role via deubiquitinating key proteins involv-
ing in DSBR pathway and/or enhance DSB response. However, there are several issues to be 
noted. First, although DUBs are a large posttranslational modification factor, only small part 
of them have functionally been identified. Second, despite DUBs that regulate DSBR capac-
ity via increasing the stability and activation of DSBR enzymes, the detailed mechanisms are 
still unclear. Finally, some other signal pathways may affect DSBR, and it is not clear whether 
DUBs regulate these signal pathways. Thus, further studies are needed to solve more detailed 
molecular mechanisms of DUBs regulating DSBR.
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AMP adenosine monophosphate
DSB DNA double-strand break
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DUB deubiquitinase
HR homologous recombination
MCPIP the monocyte chemotactic protein-induced protein
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MJD Machado-Joseph disease protein domain protease
NHEJ non-homologous end-joining
OUT ovarian tumor protease
ROS reactive oxygen species
RSS recombination signal sequence
UCH ubiquitin carboxy-terminal hydrolase
UPP ubiquitin-proteasome pathway
USP ubiquitin-specific protease
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